allowed purification requiring only a single step, but led to no detectable fusion-related enhancement of immunogenicity or quality of immune response.
INTRODUCTION
The development of cost-effective avian flu vaccines for both humans and domestic poultry is an urgent priority to prevent pandemic flu outbreaks [1] . Recombinant subunit vaccines that incorporate antigenic viral membrane glycoproteins, such as hemagglutinin (HA), are particularly attractive candidates, since these molecules can induce virus-neutralizing antibodies [2] . The HA1 antigenic domain of HA has been shown to induce an immune response equal to that of the full-size protein [3, 4] . Here, we describe the successful production of recombinant HA1 antigenic variants using transient and stable plant expression systems, a promising alternative to microbial and/or animal pharmaceutical protein production systems [5] .
MATERIALS AND METHODS

Expression of HA1 variants in plants
The Germany) were used to expedite expression [6] . To generate HA1-Fc fusions (HA1-Fc), cDNA clones encoding the heavy chain of human anti-rabies monoclonal antibody SO57 [7] and the heavy chain of murine antibody CO17-1A [8] were used as PCR templates.
HA1 and Fc fragments were joined by a flexible bridge of seven amino acids {GGGSGNS}.
Both human (HA1-hFc) and mouse (HA1-mFc) fusions were arranged using the Impact Vector system (tagged vectors # 1.1 and 1.3). The resulting cassettes carrying two 5 affinity-purification tags (c-myc and 6xHis) at the C-terminus were subcloned into the Impact binary vector AscI-PacI restriction sites and used for Agrobacterium-mediated stable transformation of tobacco plants as described [9] . The plant signal peptide for apoplast secretion and the HDEL C-terminal ER retention signal were used for transient (Nicotiana benthamiana) and stable (Nicotiana tabacum) expression, respectively.
Isolation and purification of recombinant proteins
HA-based polypeptide variants were isolated from plant tissues and purified by a 2-step procedure using His-and c-myc tags exactly as described [6] . HA-Fc fusion proteins were purified in a single-step protocol using protein A beads as described [7] . In vitro characterization and quantification of protein expression were done by ELISA and Western blot analysis as described [6, 7] . Full-size baculovirus-expressed H5 protein from BEI Resources (Manassas, VA) was used as positive control.
Immunological assessment of HA1 variants in mice
Six-to 8-week-old female BALB/c mice (5 per group) were immunized intramuscularly with recombinant peptides 2 times (two weeks interval) at a dose of 10 µg per immunization using alum-CpG adjuvant essentially as described [6] . Ten days after the last immunization, mice were sacrificed and sera from individual mice were analyzed by ELISA and Western blotting as described [6] , followed by virus micro-neutralization and hemagglutination inhibition assays [10] . Results are expressed as the mean ±SD for groups of five mice. All animal experiments were conducted in accordance with the institutional guidelines for animal welfare.
RESULTS AND DISCUSSION
Initial attempts to express the entire H5 protein (~65 kDa) or its HA1 domain (~37 kDa) in plants yielded minor quantities of the recombinant material by stable and/or transient transformation procedures (data not shown). Further testing revealed that the major part of HA1 containing the antigenic region can be efficiently expressed either as a truncated 34-or 27-kDa protein by transient system (Fig. 1A, B) or as a 37-kDa polypeptide fused at the C-terminus with a 26-kDa human or mouse Fc fragment (Fig. 1C) by stable transformation.
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All recombinant plant-produced proteins pHA1 and pHA1-Fc were present in the soluble protein fraction and showed the expected molecular weight of the resulting products. Magnicon-based expression of 34 kDa HA1 yielded up to 1 mg/kg of fresh tissue.
Stably transformed tobacco plants (>15 independent transgenic lines) confirmed high-level expression of recombinant Fc-fusion proteins, i.e., up to 4 mg/kg of fresh tissue, as determined by Western blot analysis using c-myc- (Fig. 1C) or HA1-specific antibodies (not shown). Intense secondary bands resolved from the Fc fusion constructs suggested a propensity for cleavage/degradation, especially in older leaf material (Fig. 1C, lanes   1b-3b) .
The pHA1 fragments produced by the MagnICON system were purified using a 2-step Ni ++ and c-myc chromatography procedure, while pHA1-Fc constructs were purified using single-step protein A chromatography (Fig. 1D, E) . The purification procedure increased 
Immunogenicity of HA1 protein in mice
The purified peptides from the 34kDa HA1 and HA1-Fc, HA1-mFc fusions were used to immunize mice at similar doses (~10 µg per immunization). Dosage for HA1-Fc constructs was calculated based on Western blot band intensity of commercial proteins.
ELISA analysis revealed a strong H5-specific serum IgG response to all three HA1 constructs ( Fig. 2A) , and Western blot analysis confirmed the specificity of the serum immune response against baculovirus-expressed full-size H5 and plant-derived HA1 (Fig.   2B ). High titers of mouse anti-human IgG were also detected in sera of mice immunized with pHA1-hFc (Fig. 2C) .
Several recent reports demonstrated that HA and HA1 fragment containing the majority of antigenic determinants are responsible for generation of virus-neutralizing antibodies [4, [11] [12] [13] [14] [15] . A transient expression system was successfully used to produce in 7 plants HA from A/Wyoming/03/03 (H3N2) virus that generated neutralizing antibodies in mice [11] . However, in our plant-based system, despite the high serum titers of H5-specific question also remains to whether lack of neutralizing antibodies is due to the dosage, peptide folding, purity etc. [12, 17, 18] . All these may have an impact on the ability of HA to generate a protective antibody response. Lower immunogenicity of H5 may be resolved by using better adjuvant(s) and/or different methodology of administration [19] . Further research is needed to optimize production of H5-derived antigens in plants. 
